COCH (Envoy Medical) Selling, General, & Admin. Expense: $8.80 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COCH Envoy Medical Inc COCH
6 GF Score
Price $0.75
GF Value $0.66
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Envoy Medical Selling, General, & Admin. Expense?

Envoy Medical COCH +1.50% 6 Selling, General, & Admin. Expense is $8.80 Mil as of Jun. 2026. GuruFocus rates COCH with a GF Score™ of 6/100 and a GF Value™ of $0.66 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Envoy Medical's selling, general, & admin. expense for the three months ended in Jun. 2026 was $2.21 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was $8.80 Mil.


Envoy Medical  (NAS:COCH) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Envoy Medical Selling, General, & Admin. Expense Related Terms


Envoy Medical Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Envoy Medical's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Envoy Medical Selling, General, & Admin. Expense Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
2.47 3.47 8.93 8.56 9.15

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 2.85 1.70 2.04 2.21

COCH vs ECOR, MDAI, SNWV: Selling, General, & Admin. Expense Comparison

For the Medical Devices subindustry, Envoy Medical's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envoy Medical Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Envoy Medical's Selling, General, & Admin. Expense falls into.


COCH
6GF Score
Envoy Medical Inc COCH
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of $8.80 Mil mean?
Envoy Medical (COCH) has a Selling, General, & Admin. Expense of $8.80 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Envoy Medical and its competitors.
Is Envoy Medical's Selling, General, & Admin. Expense too high?
Envoy Medical's current Selling, General, & Admin. Expense is $8.80 Mil. Overall, Envoy Medical has a GF Score™ of 6/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Selling, General, & Admin. Expense compare to ECOR and MDAI?
Envoy Medical's Selling, General, & Admin. Expense of $8.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Envoy Medical and its competitors. Envoy Medical's current Selling, General, & Admin. Expense is $8.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.66, compared to a current price of $0.75 — trading 13.6% above its estimated fair value. The current Selling, General, & Admin. Expense is $8.80 Mil. Envoy Medical's overall GF Score™ is 6/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Envoy Medical (COCH), the current Selling, General, & Admin. Expense is $8.80 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be overvalued. The current stock price of $0.75 is trading 13.6% above its estimated GF Value™ of $0.66. GuruFocus considers Envoy Medical to be Modestly Overvalued.

Key valuation signals for COCH:

  • Selling, General, & Admin. Expense: $8.80 Mil
  • GF Value™: $0.66 vs. price of $0.75 (13.6% above fair value)
  • GF Score™: 6/100 with 8 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
6GF Score

Get the complete analysis for COCH

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$0.66
GF Value